Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 19, 2018The OncologistOpen Access

Recent Advances in the Treatment of Peripheral T-Cell Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

KLKamel LaribiMAMustapha AlaniCTCatherine Truong

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Laribi et al. (2018) studied this question.

synapsesocial.com/papers/6aaa31cf33211e1322fca2b4https://doi.org/10.1634/theoncologist.2017-0524
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation2009 · 168 citations
  2. 2Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma2015 · 90 citations
  3. 3Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma2017 · 245 citations
  4. 4Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies2017 · 254 citations
  5. 5DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China2016 · 140 citations